[The new pathogenetic agent lipin for the treatment of patients with respiratory failure].

Results are submitted of clinical trial of a new drug preparation lipin based on natural phospholipids. Overall fifty-three patients with various disorders of the respiratory system complicated by the respiratory distress syndrome received the drug. Lipin was found to have a positive effect on pulmonary ventilation and oxygen-transport functions, thereby lessening arterial hypoxemia.

[The functional characteristics of the cardiovascular and respiratory systems in respiratory failure in patients with disseminated fibrous-cavernous pulmonary tuberculosis].

Resulting from complex preoperative clinico-functional examination of the 50 patients with generalized fibro-cavernous pulmonary tuberculosis, it was established that inclusion of compensatory mechanisms of the cardiovascular and respiratory systems was due to the development of chronic failure. Direction, pronouncement and interrelation of the main parameters of external respiration, oxygen transport and hemodynamics are determined by a degree of hypoxia.

[Use of decamethoxine in the complex treatment of chronic bronchitis].

Seventy-two patients with chronic bronchitis were examined and divided into 3 groups. Group I consisted of patients with chronic catarrhal bronchitis (CCB) group II of those with chronic purulent bronchitis (CPB), group III of subjects with bronchitis associated with purulent destructive pulmonary diseases. All the patients received combined treatment with decamethoxin as an antibacterial modality.